Company intelligence / Profile preview

VBI Vaccines Inc.

Cambridge, Massachusetts, United Statesvbivaccines.com ↗
Ownership
Public · VBIV
Employees
~30
Development stage
Commercial
01

Overview

VBI Vaccines had one FDA-approved product, PreHevbrio, a three-antigen hepatitis B vaccine that generated $3.1 million in sales in 2023. The company filed for bankruptcy in July 2024 and initiated a voluntary recall of PreHevbrio in October 2024 due to termination of operations[8][9].

Therapeutic areas
OncologyInfectious Diseases
Modalities
VaccinesImmunotherapeuticsVirus-like particles (VLPs)Enveloped virus-like particles (eVLPs)mRNA-launched eVLPs (MLE)
Industry
Biotech
02

Drug pipeline

13 assets

hepatitis B vaccine (recombinant, 3-antigen)

Approved

12 more assets in the full pipeline.

Request access →
03

Partnerships

Brii Biosciences (VBI-2601 IP and manufacturing deal worth up to $33 million)Valneva (European distribution of PreHevbri)[4][8]
04

Financials

Market cap
$1.9M
Total revenue
$1.2M
Enterprise value
$42M

Beyond the preview

Go deeper on VBI Vaccines Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on VBI Vaccines Inc..

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call